Attached files
| file | filename |
|---|---|
| 8-K - 8-K - NAVIDEA BIOPHARMACEUTICALS, INC. | v439340_8k.htm |
Exhibit 16.1
May 6, 2016
Securities and Exchange Commission
100 F Street N.E.
Washington, D.C. 20549
We have been furnished with a copy of the response to Item 4.01 of Form 8-K for the event that occurred on May 3, 2016, to be filed by our former client, Navidea Biopharmaceuticals, Inc. We agree with the statements made in response to that Item insofar as they relate to our Firm.
Very truly yours,
/s/ BDO USA, LLP